Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

NCT07399015 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma (mPDAC)
Unresectable Pancreatic Ductal Adenocarcinoma
Metastatic PDAC

Interventions

DRUG: mifomelatide

Sponsor

Endevica Bio